h-2b/h-2d hybrid-anti-msv-ctl immunized by h-2b , h-2d or h-2b/h-2d tumours lyse only fmrgi+ lymphomas of the same h-2 , and their activity for a given target is inhibited only by h-2-identical competitive cells .
C0024264
ctl
C0024299
lymphomas